INDIA COURT REFERS PATENT ROW OVER GLEEVEC TO 2-JUDGE PANEL

A southern Indian court judge on Tuesday referred a patent dispute over the popular cancer drug Gleevec to a two-judge tribunal, saying the importance of the questions involved required a larger panel, according to a lawyer. Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=62904&lang=fra&NewsRubrique=2)